To access European markets, integrated healthcare company Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) has started trading on the Frankfurt Stock Exchange.
In a statement Friday, the firm says trading started that day under the symbol “KL1” on one of the world’s largest stock exchanges.
“Listing on the Frankfurt Stock Exchange will provide Pathway Health with direct access to the European capital markets and an opportunity for the company to increase trading liquidity and facilitate investment by expanding our shareholder base,” CEO Ken Yoon said in a statement.
Frankfurt is the largest of Germany’s seven stock exchanges and it’s an international trading centre. Of about 200 market participants, roughly 50 are from countries other than Germany.
“The FSE facilitates advanced electronic trading, settlement and information systems, allowing it to meet the growing requirements of cross-border trading,” Pathway adds.
The healthcare company owns and operates nine community-based clinics in four Canadian provinces. Pathway says it services patients suffering from chronic pain and related conditions through evidence-based approaches and products, including medical cannabis.
This year, the firm has partnered with some Canadian pharmacies to implement Pathway’s medical cannabis system.
Pathway says it anticipates changes to Canada’s Cannabis Act, and is working with pharmacy firms to develop cannabis products for other-the-counter distribution in retail pharmacies.